Stem cell mobilization in resistant or relapsed lymphoma: Superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide

British Journal of Haematology

Volumn 98, Issue 1, 1997, Pages 228-233

  Mcquaker, I G ^a   Haynes, A P ^a,b   Stainer, C ^a   Anderson, S ^a   Russell, N H ^a,b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

CD34+ cells; Lymphoma; Peripheral blood stem cells; Stem cell mobilization; Transplantation

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CELL SUBPOPULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030852837     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.1812998.x     Document Type: Article

References (27)

1. Ager, S., Scott, M.A., Mahendra, P., Richards, E.M., Jestice, H.K., Boraks, P., Baglin, T.P. & Marcus, R.E. (1995) Peripheral blood stem cell transplantation after high-dose therapy in patients with malignant lymphoma: a retrospective comparison with autologous bone marrow transplantation. Bone Marrow transplantation, 16, 79-83.
2. Bender, J.G., William, S.F., Meyers, S., Nottleman, D., Lee, W.J., Unverzagt, K.L., Walker, D., To, L.B. & Vanepps, D.E. (1992) Characterisation of chemotherapy mobilised peripheral-blood progenitor cells for use in autologous stem cell transplantation. Bone Murrow transplantation, 13, 157-162.
3. Colombat, P., Donadio, D., Fouillard, L., Milpied, N., Tilly, H., Pico, J., Abgrall, J.F., Coiffier, B., Hebrecht, R. & Philip, T. (1994) Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. Bone Marrow transplantation, 13, 157-162.
4. Cullen, M.H., Stuart, N.S.A., Woodroffe, C., Murphy, A., Fletcher, J., Blackledge, G.R.P., Child, J.A., Grieve, R.J., Jones, E.L., Chetiyawardana, A.D., Earl, H.M., Galvin, G.P., Andrews, V.E., Harper, P., Lewis, M.L., Mould, J.J., Murray, J.A., Norfolk, D.R., Obeid, D., Offerman, E.L., Spooner, D., Stableforth, P.G. & Tucker, J. (1994) ChIVPP/PABIOE and radiotherapy in advanced Hodgkins disease. Journal of Clinical Oncology, 12, 779-787.
5. Demirer, T., Buckner, C.D., Gooley, T., Applelbaum, F.R., Rowley, S., Chauncey, T., Lilleby, K., Storh, R. & Bensinger, W.I. (1996) Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow transplantation, 17, 937-941.
6. Dreger, P., Marquardt, P., Haferlach, T., Jacobs, S., Mulverstedt, T., Eckstein, V., Suttorp, M., Loffler, H., Muller-Ruchholtz, W. & Schmitz, N. (1993) Effective mobilization of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product. British Journal of Cancer, 950-957.
7. Freedman, A.S., Ritz, J., Neuberg, D., Anderson, K.C., Rabinowe, S.N., Mauch, P., Takvorian, T., Soiffer, R., Blake, B., Coral, F. & Nadler, L.M. (1991) Autologous bone marrow transplantation in 69 patients with a history of low-grade non-Hodgkin's lymphoma. Blood, 77, 2524-2529.
8. Freedman, A.S., Takvorian, T., Anderson, K.C., Mauch, P., Rabinowe, S.N., Blake, K., Yeap, B., Soiffer, R., Coral, F.. Heflin, L., Ritz, J. & Nadler, L.M. (1990) Autologous bone-marrow transplantation in B-Cell non-Hodgkins lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. Journal of Clinical Oncology, 8, 784-791.
9. 2) and granulocyte colonystimulating factor in patients with multiple myeloma. Bone Marrow Transplantation, 17, 691-697.
10. Gratwohl, A., Hermans, J., Baldomero, A., Tichelli, A., Goldman, J.M. & Gharton, G. (1996) Indications for haemopoietic precursor cell transplants in Europe, British Journal of Haematology, 92, 35-43.
11. Gribben, J.G., Goldstone, A.H., Linch, D.C., Taghipour, G., McMillan, A.K., Souhami, R.L., Earl, H. & Richards, J.D.M. (1989) Effectiveness of high-dose combination chemotherapy and autologous bone-marrow transplantation for patients with non-Hodgkins lymphomas who are still responsive to conventional-dose therapy. Journal of Clinical Oncology, 7, 1621-1629.
12. Haas, R., Moos, M., Karcher, A., Mohle, R., Witt, B., Goldschmidt, H., Fruhauf, S., Flentji, M., Wannenmacher. M. & Hunstein, W. (1994) Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 1685-1692.
13. Haynes, A.P., Hunter, A., McQuaker, G., Anderson, S., Bienz, N., Mitchell, D. & Russell, N.H. (1995) Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplantation, 16, 359-365.
14. Jones, H.M., Jones, S.A., Watts, M.J., Khwaja, A., Mills, W., Fielding, A., Goldstone, A.H. & Linch, D.C. (1994) Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. Journal of Clinical Oncology, 12, 1693-1702.
15. Lie, A.K.W., Rawling, T.P., Bayly, J.L. & To, L.B. (1996) Progenitor cell yield in sequential blood stem cell mobilization in the same patients: insights into chemotherapy dose escalation and combination of haemopoietic growth factor and chemotherapy. British Journal of Haematology, 95, 39-44.
16. McQuaker, I.G.. Haynes, A.P., Anderson, S., Stainer, C., Owen, R.G., Morgan, G.J., Lumley, M., Milligan, D., Fletcher, J., Bessell, E.M., Davies, J.M. & Russell, N.H. (1997) Engraftment and molecular monitoring of CD34 positive peripheral blood stem cell transplants for follicular lymphoma. Journal of Clinical Oncology (in press).
17. Morel, P., Laporte, J.P., Noel, M.P., Douay, L., Fouillard, L., Detourmignies, L., Dupriez, B., Lesage, S., Isnard, F., Grande, M., Jouet, J.P., Najman, A., Bauters, F. & Gorin, N.C. (1995) Autologous bone marrow transplantation as a consolidation therapy may prolong remission in newly diagnosed high-risk follicular lymphoma: a pilot study of 34 cases. Leukemia, 9, 576-582.
18. Pettengell, R., Testa, N.G., Swindell, R., Crowther, D. & Dexter, T.M. (1993) Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood, 82, 2239-2248.
19. Philip, T., Armitage, J.O., Spitzer, G., Chauvin, F., Jagannath, S., Cahn, J.-Y., Colombat, P., Goldstone, A.H., Gorin, N.C., Flesh, M., Laporte, J.-P., Maraninchi, D., Pico, J., Bosly, A., Anderson, C., Schots, R., Biron, P., Cabanillas, F. & Dicke, K. (1987) High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. New England Journal of Medicine, 316, 1493-1498.
20. Rohatiner, A.Z.S., Johnson, P.W.M., Price, C.G.A., Arnott, S.J., Amess, J.A.L., Norton, A.J., Dorey, E., Adams, K., Whelan, J.S., Matthews, P., MacCallum, P.K. & Lister, T.A. (1994) Myeloablative therapy with autologous bone marow transplantation as consolidation therapy for recurrent follicular lymphoma. Journal of Clinical Oncology, 12, 1177-1184.
21. Russell, N.H. & Pacey, S. (1992) Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet, 540, 1280.
22. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Booggerts, M.A., Ferrant, A., Demuynck, H.M.S., Zander, A. & Borkett, K. (1996) A randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet, 347, 3563-3357
23. Schouten, H.C., Bierman, P.J., Vaughan, W.P., Kessinger, A., Vose, J.M., Weisenburger, D.D. & Armitage, J.O. (1989) Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histological transformation. Blood. 74, 2579-2584.
24. + hematopoietic stem-cells in the peripheral-blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 74, 1905-1914.
25. To, L.B., Roberts, M.M., Haylock, D.N., Dyson, P.G., Branford, A.L., Thorp, D., Ho, J.Q.K., Dart, G.W., Horvath, N., Davy, M.L.J., Olweny, C.L.M., Abdi, E. & Juttner, C.A. (1992) Comparison of haematological recovery times and supportive care requirements for autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplantation, 9, 277-284.
26. To, L.B., Shepperd, K.M., Haylock, D.N., Dyson., P.G., Charles, P., Thorp, U.L., Dale, B.M., Dart, G.W., Roberts, M.M., Sage, R.E. & Juttner, C.A. (1990) Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Experimental Hematology, 18, 442-447.
27. Zinzani, P.L., Barbieri, E., Visani, G., Gherlinzoni, F., Perini, F., Neri, S., Bendandi, M., Ammendolia, I., Salvucci, M., Babini, L. & Tura, S. (1994) Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkins lymphoma and Hodgkins disease. Haematologica, 79, 508-512.